Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Morgan Stanley from $70.00 to $38.00 in a report ...
Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for shares of Moderna in a note issued to investors ...
Moderna's been anything but a high-flying growth stock in this investor's portfolio. So is it high time he gave up on this ...
The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the developme ...
CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...
Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.
SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...
US stocks saw a decline on Monday as investors continued to unload key tech shares that have been driving the bull market.
Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says.
Moderna Inc. (NYSE: MRNA) has revised its sales projections for 2025, lowering expectations due to sluggish demand for its ...